DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS 21 Canada - English - Health Canada

drospirenone and ethinyl estradiol tablets 21

mylan pharmaceuticals ulc - drospirenone; ethinyl estradiol - tablet - 3mg; 0.03mg - drospirenone 3mg; ethinyl estradiol 0.03mg - progestogens and estrogens, fixed combinations

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS 28 Canada - English - Health Canada

drospirenone and ethinyl estradiol tablets 28

mylan pharmaceuticals ulc - drospirenone; ethinyl estradiol - tablet - 3mg; 0.03mg - drospirenone 3mg; ethinyl estradiol 0.03mg - contraceptives

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 28 Canada - English - Health Canada

drospirenone and ethinyl estradiol tablets usp 28

glenmark pharmaceuticals canada inc. - drospirenone; ethinyl estradiol - tablet - 3mg; 0.03mg - drospirenone 3mg; ethinyl estradiol 0.03mg - contraceptives

DROSPIRENONE AND ETHINYL ESTRADIOL-  drospirenone and ethinyl estradiol  kit United States - English - NLM (National Library of Medicine)

drospirenone and ethinyl estradiol- drospirenone and ethinyl estradiol kit

nivagen pharmaceuticals, inc. - drospirenone (unii: n295j34a25) (drospirenone - unii:n295j34a25), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - drospirenone and ethinyl estradiol tablets are indicated for use by women to prevent pregnancy. drospirenone and ethinyl estradiol tablets are also indicated for the treatment of symptoms of premenstrual dysphoric disorder (pmdd) in women who choose to use an oral contraceptive as their method of contraception. the effectiveness of drospirenone and ethinyl estradiol tablets for pmdd when used for more than three menstrual cycles has not been evaluated. the essential features of pmdd according to the diagnostic and statistical manual-4th edition (dsm-iv) include markedly depressed mood, anxiety or tension, affective lability, and persistent anger or irritability. other features include decreased interest in usual activities, difficulty concentrating, lack of energy, change in appetite or sleep, and feeling out of control. physical symptoms associated with pmdd include breast tenderness, headache, joint and muscle pain, bloating and weight gain. in this disorder, these symptoms occur regularly during the luteal

Ethinylestradiol/Drospirenone Leon Farma & Placebo 0.02 mg/3 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

ethinylestradiol/drospirenone leon farma & placebo 0.02 mg/3 mg film-coated tablets

laboratorios leon farma, s.a. - drospirenone; ethinylestradiol - film-coated tablet - 0.02/3 milligram(s) - progestogens and estrogens, fixed combinations; drospirenone and ethinylestradiol

MEGESTROL ACETATE tablet United States - English - NLM (National Library of Medicine)

megestrol acetate tablet

avera mckennan hospital - megestrol acetate (unii: tj2m0fr8es) (megestrol - unii:ea6ld1m70m) - megestrol acetate 40 mg

MEGESTROL ACETATE tablet United States - English - NLM (National Library of Medicine)

megestrol acetate tablet

cardinal health - megestrol acetate (unii: tj2m0fr8es) (megestrol - unii:ea6ld1m70m) - megestrol acetate 40 mg

MEGESTROL ACETATE suspension United States - English - NLM (National Library of Medicine)

megestrol acetate suspension

avkare, inc. - megestrol acetate (unii: tj2m0fr8es) (megestrol - unii:ea6ld1m70m) - megestrol acetate 125 mg in 1 ml

CHOLESTEROL- cholesterinum liquid United States - English - NLM (National Library of Medicine)

cholesterol- cholesterinum liquid

deseret biologicals, inc. - cholesterol (unii: 97c5t2uq7j) (cholesterol - unii:97c5t2uq7j) - cholesterol 6 [hp_x] in 1 ml - for temporary relief of symptoms related to adrenal glands such as fatigue and low energy.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to adrenal glands such as fatigue and low energy.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.